Featured Stories

Expanded Zebrafish PCR Testing


The 360 Diagnostics™ R&D team recently completed the validation of new PCR assays for infectious diseases that commonly affect zebrafish colonies. 

New Chief Scientific Officer


Dr. David Hutto recently joined our team as the Chief Scientific Officer for the Safety Assessment division. Dr. Hutto will ensure the quality and alignment of the safety assessment sciences across all relevant units and sites within Charles River.

The Longest Day at Charles River


Inspired by the Alzheimer's Association's nationwide fundraising event hosted annually on the summer solstice, Charles River’s Longest Day promoted Alzheimer’s disease education, brain health and physical activity at our sites globally.

Charles River Completes Acquisition of Celsis


Charles River has acquired Celsis International Ltd, a leading provider of rapid microbial detection systems for quality control testing in the biopharmaceutical and consumer products industries. The combination of Charles River and Celsis will drive significant value for our clients’ in-process and product release testing needs across a broad range of microbial detection applications.

Displaying results 1-10 (of 192)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >|